Hayne Cho Park Selected Research

Hayne Cho Park Research Topics

14	Autosomal Dominant Polycystic Kidney (ADPKD) 09/2023 - 02/2009
6	Chronic Renal Insufficiency 10/2023 - 01/2016
6	Cysts 06/2022 - 02/2009
5	Infections 01/2024 - 07/2012
4	Malnutrition (Nutritional Deficiencies) 08/2023 - 01/2017
3	COVID-19 01/2024 - 01/2020
3	Chronic Kidney Failure (Chronic Renal Failure) 01/2024 - 05/2014
3	Coronavirus Infections 06/2020 - 06/2017
2	Neoplasms (Cancer) 01/2024 - 01/2023
2	Anemia 10/2023 - 12/2021
2	Polycystic liver disease 09/2023 - 01/2015
2	Inflammation (Inflammations) 08/2023 - 01/2019
2	Disease Progression 07/2022 - 01/2016
2	Hemorrhagic Fever with Renal Syndrome (HFRS) 01/2022 - 01/2021
1	Proteinuria 10/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2023
1	Arteriovenous Fistula 01/2023
1	Pain (Aches) 01/2023
1	Renal Insufficiency (Renal Failure) 06/2022
1	Polycystic Kidney Diseases (Polycystic Kidney Disease) 06/2022
1	Cystic Kidney Diseases (Cystic Kidney Disease) 01/2021
1	Severe Acute Respiratory Syndrome 01/2020
1	Cross Infection (Nosocomial Infection) 01/2020
1	Hypophosphatemia 01/2020
1	Hypokalemia 01/2020
1	Pyelonephritis 06/2019
1	Vascular Calcification 01/2019
1	Albuminuria 01/2019
1	Hypoalbuminemia 01/2019
1	Fever (Fevers) 07/2018
1	Communicable Diseases (Infectious Diseases) 03/2018
1	Hypertension (High Blood Pressure) 06/2015
1	Back Pain (Backache) 01/2015
1	Flank Pain 01/2015
1	Hernia (Hernias) 01/2015
1	Edema (Dropsy) 01/2015
1	Dyspnea (Shortness of Breath) 01/2015
1	Ascites 01/2015
1	Reperfusion Injury 10/2011

7	Biomarkers (Surrogate Marker)IBA 07/2022 - 08/2012
4	Hemoglobins (Hemoglobin)IBA 01/2022 - 01/2017
3	Tolvaptan FDA Link 03/2023 - 06/2022
3	CreatinineIBA 01/2022 - 05/2014
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2024 - 06/2013
2	1-dodecylpyridoxal (PLD)IBA 09/2023 - 01/2015
2	AngiotensinogenIBA 06/2020 - 06/2015
2	Serum AlbuminIBA 01/2019 - 01/2019
2	C-Reactive ProteinIBA 01/2019 - 07/2018
1	regdanvimabIBA 01/2024
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2023
1	Angiotensin Receptor AntagonistsIBA 10/2023
1	MineralsIBA 10/2023
1	ElectrolytesIBA 08/2023
1	PlasticsIBA 01/2023
1	MetalsIBA 01/2023
1	AlbuminsIBA 01/2023
1	SodiumIBA 06/2022
1	Adenosine Monophosphate (AMP)IBA 06/2022
1	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 06/2022
1	ImmunosorbentsIBA 01/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2022
1	EnzymesIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Cystatin CIBA 01/2022
1	Erythropoietin FDA Link 12/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	CarbonIBA 01/2021
1	Capsules (Microcapsules)IBA 01/2021
1	IndicanIBA 01/2021
1	Phosphates (Orthophosphate)IBA 01/2020
1	insulin receptor-related receptor (IRR)IBA 01/2020
1	PotassiumIBA 01/2020
1	Alkaline PhosphataseIBA 06/2019
1	TransferasesIBA 06/2019
1	Blood Glucose (Blood Sugar)IBA 01/2019
1	LDL CholesterolIBA 01/2019
1	Contrast MediaIBA 07/2018
1	Fluorine-18IBA 05/2016
1	MucinsIBA 10/2015
1	ReninIBA 06/2015
1	Hexosaminidases (Hexosaminidase)IBA 08/2012
1	Polyvinyl AlcoholIBA 02/2009

11	Renal Dialysis (Hemodialysis) 01/2024 - 01/2016
3	Therapeutics 06/2020 - 02/2009
1	Catheters 01/2023
1	Cannula 01/2023
1	Conservative Treatment 06/2022
1	Sodium-Restricted Diet (Diet, Sodium Restricted) 06/2022
1	Precision Medicine 01/2021
1	Continuous Renal Replacement Therapy 01/2020
1	Length of Stay 06/2019
1	Aftercare (After-Treatment) 01/2016
1	Renal Replacement Therapy (Therapies, Renal Replacement) 07/2012
1	Transplantation 10/2011